HonorHealth First in Arizona to Deploy Perimeter's Groundbreaking Visualization Technology in Surgery
Perimeter Medical Imaging AI announced that HonorHealth, a major healthcare system in Phoenix and Scottsdale, has become Arizona's first to implement their S-Series OCT technology for visualizing tissue margins during surgery.
The groundbreaking Optical Coherence Tomography technology offers superior resolution compared to traditional imaging methods, enabling visualization at the cellular level. It creates 3D images with 10 times the resolution of ultrasound and X-ray, and 100 times that of MRI, helping surgeons make real-time decisions during procedures.
Key advantages include:
- 2mm resolution optimization for tissue microstructures
- Real-time visualization of surgical margins
- FDA clearance for general tissue imaging since 2021
This deployment represents a significant expansion of Perimeter's commercial presence in the Southwest, potentially reducing the need for follow-up surgeries that typically result from waiting up to 10 days for traditional pathology results.
Perimeter Medical Imaging AI ha annunciato che HonorHealth, un importante sistema sanitario di Phoenix e Scottsdale, è diventato il primo in Arizona ad adottare la tecnologia S-Series OCT per visualizzare i margini tissutali durante gli interventi chirurgici.
La rivoluzionaria tecnologia di Tomografia a Coerenza Ottica offre una risoluzione superiore rispetto ai metodi di imaging tradizionali, permettendo la visualizzazione a livello cellulare. Produce immagini 3D con una risoluzione 10 volte superiore a quella di ecografia e radiografia, e 100 volte superiore a quella della risonanza magnetica, aiutando i chirurghi a prendere decisioni in tempo reale durante le procedure.
I principali vantaggi includono:
- Ottimizzazione della risoluzione a 2 mm per le microstrutture tissutali
- Visualizzazione in tempo reale dei margini chirurgici
- Autorizzazione FDA per l'imaging generale dei tessuti dal 2021
Questa implementazione rappresenta un'importante espansione della presenza commerciale di Perimeter nel Sud-Ovest, con il potenziale di ridurre la necessità di interventi chirurgici successivi, solitamente causati dall'attesa fino a 10 giorni per i risultati della patologia tradizionale.
Perimeter Medical Imaging AI anunció que HonorHealth, un importante sistema de salud en Phoenix y Scottsdale, se ha convertido en el primero en Arizona en implementar su tecnología S-Series OCT para visualizar los márgenes tisulares durante la cirugía.
La innovadora tecnología de Tomografía de Coherencia Óptica ofrece una resolución superior en comparación con los métodos tradicionales de imagen, permitiendo la visualización a nivel celular. Genera imágenes 3D con una resolución 10 veces mayor que la de ultrasonido y rayos X, y 100 veces mayor que la de resonancia magnética, ayudando a los cirujanos a tomar decisiones en tiempo real durante los procedimientos.
Las ventajas clave incluyen:
- Optimización de resolución de 2 mm para microestructuras tisulares
- Visualización en tiempo real de los márgenes quirúrgicos
- Aprobación de la FDA para imagen general de tejidos desde 2021
Esta implementación representa una expansión significativa de la presencia comercial de Perimeter en el suroeste, con el potencial de reducir la necesidad de cirugías posteriores que normalmente resultan de esperar hasta 10 días para los resultados de patología tradicional.
Perimeter Medical Imaging AI는 피닉스와 스코츠데일의 주요 의료 시스템인 HonorHealth가 수술 중 조직 경계를 시각화하기 위해 자사의 S-Series OCT 기술을 아리조나 주 최초로 도입했다고 발표했습니다.
혁신적인 광학 단층 촬영 기술은 기존 영상 기법에 비해 우수한 해상도를 제공하며, 세포 수준의 시각화를 가능하게 합니다. 초음파 및 엑스레이 해상도의 10배, MRI 해상도의 100배에 달하는 3D 영상을 생성하여 수술 중 실시간 의사 결정을 지원합니다.
주요 장점은 다음과 같습니다:
- 조직 미세구조를 위한 2mm 해상도 최적화
- 수술 경계의 실시간 시각화
- 2021년부터 일반 조직 영상에 대한 FDA 승인 획득
이번 도입은 Perimeter가 미국 남서부 지역에서 상업적 입지를 크게 확장하는 의미가 있으며, 전통적인 병리 검사 결과를 최대 10일간 기다려야 하는 상황에서 발생하는 추가 수술 필요성을 줄일 수 있을 것으로 기대됩니다.
Perimeter Medical Imaging AI a annoncé que HonorHealth, un important système de santé à Phoenix et Scottsdale, est devenu le premier en Arizona à déployer leur technologie S-Series OCT pour visualiser les marges tissulaires pendant la chirurgie.
La technologie révolutionnaire de Tomographie par Cohérence Optique offre une résolution supérieure aux méthodes d'imagerie traditionnelles, permettant une visualisation au niveau cellulaire. Elle génère des images 3D avec une résolution 10 fois supérieure à celle de l’échographie et des rayons X, et 100 fois supérieure à celle de l’IRM, aidant les chirurgiens à prendre des décisions en temps réel pendant les interventions.
Les avantages clés incluent :
- Optimisation de la résolution à 2 mm pour les microstructures tissulaires
- Visualisation en temps réel des marges chirurgicales
- Autorisation FDA pour l’imagerie générale des tissus depuis 2021
Cette mise en place représente une expansion majeure de la présence commerciale de Perimeter dans le Sud-Ouest, avec un potentiel de réduction des interventions chirurgicales supplémentaires souvent nécessaires en raison d’une attente pouvant aller jusqu’à 10 jours pour les résultats de pathologie traditionnelle.
Perimeter Medical Imaging AI gab bekannt, dass HonorHealth, ein bedeutendes Gesundheitssystem in Phoenix und Scottsdale, als erstes in Arizona ihre S-Series OCT-Technologie zur Visualisierung von Geweberändern während Operationen einsetzt.
Die bahnbrechende Optische Kohärenztomographie-Technologie bietet eine überlegene Auflösung im Vergleich zu herkömmlichen Bildgebungsverfahren und ermöglicht die Visualisierung auf zellulärer Ebene. Sie erzeugt 3D-Bilder mit einer 10-fach höheren Auflösung als Ultraschall und Röntgen sowie 100-fach höher als MRT, was Chirurgen hilft, während der Eingriffe Echtzeit-Entscheidungen zu treffen.
Wichtige Vorteile sind:
- Optimierte 2-mm-Auflösung für mikroskopische Gewebestrukturen
- Echtzeit-Visualisierung der Operationsränder
- FDA-Zulassung für allgemeine Gewebeabbildung seit 2021
Diese Einführung stellt eine bedeutende Erweiterung der kommerziellen Präsenz von Perimeter im Südwesten dar und könnte die Notwendigkeit von Nachoperationen verringern, die typischerweise durch Wartezeiten von bis zu 10 Tagen auf traditionelle Pathologieergebnisse entstehen.
- First-to-market advantage in Arizona with OCT technology deployment
- Successful commercial expansion into major Southwest US metropolitan area
- Technology offers 10x resolution of ultrasound/X-ray and 100x of MRI
- FDA clearance already obtained for general tissue imaging
- Technology reduces patient wait times from 10 days to real-time results
- None.
"Having the most advanced technologies in the operating room to assist my decision-making in real-time is incredibly valuable," said Dr. Sommer Gunia, a breast surgical oncologist with HonorHealth. "OCT imaging technology allows me to see at a depth and resolution that was previously impossible in the OR, and it has become an important tool that helps me achieve the best possible outcomes for my patients."
Traditional technologies such as X-ray, ultrasound or magnetic resonance imaging ("MRI") don't have the resolution to see disease at the cellular level. As a result, surgeons must wait up to 10 days for pathology results to either confirm clean margins or show positive margins, which often result in patients returning for another procedure. The resolution of the S-Series OCT is optimized down to 2 mm for identifying regions of interest in tissue microstructures and features such as blood vessels, ducts and glands, making it ideal for visualizing surgical margins and helping surgeons to make the best surgical decisions for their patients. It uses light to create cross-sectional 3D images of tissue microstructures at 10 times the resolution of ultrasound and X-ray and 100 times the resolution of MRI. The S-Series OCT was cleared by the
"HonorHealth's adoption of the S-Series OCT continues our nationwide commercial expansion and increases patient access to the technology in one of the most populous metropolitan areas in the Southwest," said Perimeter CEO Adrian Mendes. "The ongoing adoption of our S-Series OCT reflects both the need for enhanced margin visualization in the operating room and confidence in our technology to improve patient outcomes. We are thrilled to partner with HonorHealth."
About Perimeter Medical Imaging AI, Inc.
Based in
S-Series OCT Intended Use and Unapproved Uses
The S-Series OCT is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization with image review manipulation software for identifying and annotating regions of interest. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, statements regarding the anticipated terms and jurisdictions of the Offering; securities offered thereunder; the timing of the Offering, including the anticipated Closing Date; use of proceeds from the Offering; fees anticipated to be paid to the Agent and terms thereof; regulatory and exchange approvals, including the listing of the common shares offered pursuant to the Offering on the TSXV, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Annual Information Form for the year ended December 31, 2024, which is available on Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.
Contacts
Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: skilmer@perimetermed.com
Susan Thomas
Media Relations
Direct: 619-540-9195
Email: susan@endpointcommunications.net
Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: investors@perimetermed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/honorhealth-first-in-arizona-to-deploy-perimeters-groundbreaking-visualization-technology-in-surgery-302442265.html
SOURCE Perimeter Medical Imaging AI Inc.
FAQ
What technology did HonorHealth deploy from Perimeter Medical (PYNKF) in 2025?
How does Perimeter Medical's (PYNKF) OCT technology compare to traditional imaging methods?
What is the clinical benefit of Perimeter Medical's (PYNKF) S-Series OCT system?
When did the FDA clear Perimeter Medical's (PYNKF) S-Series OCT technology?
What market expansion does the HonorHealth partnership represent for Perimeter Medical (PYNKF)?
